New article from Tim Noble shows how to cluster LinkedIn skill endorsements into practical signals for executive ...

Background Modelling studies find the smokefree generation (SFG) policy could help achieve the tobacco endgame. The UK is on ...

A domestic research team has developed an ultra-fast analysis technology capable of simultaneously tracking the evolutionary process of proteins spanning billions of years. With the advancement of ...

Bitcoin soars in early 2025 on election of crypto-friendly President Trump, drop later in year on tariff news Analysts cite correlation between bitcoin and risk assets like equity markets Crypto ...

Our region has reduced vulnerabilities in the language and cognitive development domain, according to the Early Development Instrument (EDI). As a community, can we argue that our collective efforts ...

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--TD Bank, America’s Most Convenient Bank ®, today announced that the bank will consolidate its Mid-South Metro segment into two newly defined regions, the ...

The new four-region model consolidates leadership and operations to enhance operating model, client delivery and accelerate execution across the footprint TD Bank, America’s Most Convenient Bank®, ...

This past week’s real-time sentiment data shows something important has changed. The electorate hasn’t cooled off. It has lined up. Across millions of data points tracked by EyesOver between December ...

Legislative text has been circulating privately among industry insiders, and executives took a look at some of the current draft in a White House meeting on Thursday, according to people familiar with ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...